Medications

FDA Approves First Treatment for Ebola

On October 14, through immediate press-release FDA (Food and Druf Administration of U.S.) approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies,…




Acella Recalls Thyroid Medications

Acella Pharmaceuticals, LLC recalls recalling one lot of 15-mg and one lot of 120-mg NP Thyroid, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to…


Hikma Launches Azacitidine

On September 10, Hikma Pharmaceuticals PLC (Hikma), at London announced Azacitidine for Injection, 100 mg, the generic version of Vidaza, in the United States it…


FDA Approval For RET Cancer Drug Gavreto

Recently FDA Okayed Gavreto (pralsetinib) for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancer. Gavreto approved under the FDA’s accelerated approval…





FDA Balks At Bayshore Recall

After the information from FDA about Bayshore Pharmaceuticals, LLC recall. It was a voluntary nationwide Bayshore recall of metformin hydrochloride extended-release tablets. The FDA begins…